tratamento da esquistossomose com oxamniquine (xarope) em crianças

Clicks: 9
ID: 259522
1975
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #256 of 272 articles by views in mobile information systems

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 272 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Foram tratados pela oxamniquine, sob a forma de xarope, 75 esquistossomôticos. com idade de 3 a 12 anos, distribuídos uniformente por quatro grupos, utilizando-se os esquemas de 15, 20 e 25 mg por quilo de peso corporal, em dose única e 20mg subdivididos em duas doses com intervalo de quatro horas. O controle de cura foi feito com cinco exames de fezes no período de seis meses. A dose de 20 mg, mesmo subdividida, apresentou os melhores resultados com 94,7% de cura e boa tolerabilidade. A dose de 15 mg, embora sendo a melhor tolerada, deu somente 62,5 % de cura. A dose de 25 mg foi a que apresentou pior tolerância. A eficácia das doses de oxamniquine aumenta com a idade das , crianças tratadas.
75 patients aged 3 to 12 years were divided equally into 4 groups and treated with oxamniquine syrup in doses of 15, 20 and 25 mg per kg/body weight given as a single dose and 20 mg divided into two doses with an interval of 4 hours between doses. The control of cure was 5 faecal examinations performed consecutively during a period of six months. The divided dose of 20 mg gave very good results with 94.7% cure and good tolerance. The 15 mg dose although well tolerated gave only 62.5% cure. A 25 mg single dose was poorly tolerated. The efficacy of the dose of oxamniquine rose with the age of child treated.
Reference Key
bina1975revistatratamento Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;J. C. Bina;A. Prata
Journal mobile information systems
Year 1975
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.